Press Releases GE HealthCare Technologies Inc.

Stocks

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 01:30:00 15/07/2026 am IST			After hours 05:30:00 am
61.66 ^USD	-5.59%		75.00	+21.63%

14/07	Elekta slides on worries over Chinese procurement - EFN	FW
13/07	BTIG Research Adjusts GE Healthcare Technologies Price Target to $75 From $80, Maintains Buy Rating	MT

Press Releases

08/07	GE HealthCare and Mayo Clinic aim to advance personalized cancer treatment through new theranostics research collaboration	BU
08/07	GE HealthCare Technologies : and Mayo Clinic aim to advance personalized cancer treatment through new theranostics research collaboration	PU
08/07	GE HealthCare to announce second quarter 2026 results on July 29, 2026	BU
30/06	GE HealthCare announces cash dividend for second quarter of 2026	BU
29/06	GE HealthCare introduces Allia upgrade pathways designed to modernize existing interventional suites	BU
09/06	GE HealthCare advancing enterprise imaging with cloud-enabled solutions	BU
05/06	GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtegeAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities	AQ
04/06	GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities	BU
01/06	GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations	BU
12/05	ESTRO 2026 Congress: GE HealthCare to spotlight AI-enabled solutions to advance precision care across radiation therapy and image-guided interventions	BU
11/05	GE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impact	BU
29/04	GE HealthCare Technologies : GEHC Slides 1Q'26 Earnings FINAL	PU
29/04	GE HealthCare Technologies : GEHC Release 1Q'26 Earnings FINAL	PU
29/04	GE HealthCare: Q1 Earnings Snapshot	AQ
29/04	GE HealthCare announces executive team and operational updates to enhance execution, accelerate innovation, and drive growth	BU
29/04	GE HealthCare reports first quarter 2026 financial results	BU
27/04	GE HealthCare management to present at upcoming investor conferences	BU
23/04	GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents	BU
17/04	GE HealthCare expands mammography collaboration with RadNet’s DeepHealth subsidiary to extend global access to DeepHealth’s AI-powered breast cancer screening solutions	BU
10/04	GE HealthCare Technologies : 2025 Annual Report	PU
10/04	GE HealthCare Technologies : 2026 Proxy Statement	PU
09/04	GE HealthCare announces digital integration between bkActiv™ intraoperative ultrasound system and Medtronic Stealth AXiS™ surgical navigation system	BU
06/04	GE HealthCare to announce first quarter 2026 results on April 29, 2026	BU
01/04	GE HealthCare Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited	BU
26/03	GE HealthCare announces lead industrial role in largest EU-funded IHI consortium to advance cardio-oncology care across Europe	BU